676348-49-5

Basic information

• Product Name: (E)-3-(4-BROMO-2-FLUOROPHENYL)ACRYLOYL CHLORIDE
• Synonyms: 3-(4-BROMO-2-FLUORO-PHENYL)-ACRYLOYL CHLORIDE;(E)-3-(4-BROMO-2-FLUOROPHENYL)ACRYLOYL CHLORIDE
• CAS NO: 676348-49-5
• Molecular Formula: C9H5BrClFO
• Molecular Weight: 263.49
• Mol File: 676348-49-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (E)-3-(4-BROMO-2-FLUOROPHENYL)ACRYLOYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-3-(4-BROMO-2-FLUOROPHENYL)ACRYLOYL CHLORIDE(676348-49-5)
• EPA Substance Registry System: (E)-3-(4-BROMO-2-FLUOROPHENYL)ACRYLOYL CHLORIDE(676348-49-5)

Safety Data

• Hazardous Substances Data: 676348-49-5(Hazardous Substances Data)

Usage

General Description

(E)-3-(4-bromo-2-fluorophenyl)acryloyl chloride is a chemical compound with the molecular formula C9H5BrClF. It is an acryloyl chloride derivative, which means it contains a reactive acyl chloride group attached to an acryloyl group. (E)-3-(4-BROMO-2-FLUOROPHENYL)ACRYLOYL CHLORIDE is used as a building block in organic synthesis, particularly in the preparation of pharmaceuticals and agrochemicals. The (E)-configuration indicates that the bromine and fluorine substituents are on opposite sides of the double bond in the acryloyl group. It is a highly reactive compound and should be handled with care, as it can react vigorously with water and alcohols, releasing toxic hydrogen chloride gas.

Upstream product

• 575469-65-7 3-(4-bromo-2-fluorophenyl)-2-propenoic acid 

Downstream Products

• 1588867-01-9 (E)-diisopropyl (3-(4-bromo-2-fluorophenyl)acryloyl)phosphonate 

Relevant articles and documents

Design, Synthesis, Structure-Activity Relationship, Molecular Docking, and Herbicidal Evaluation of 2-Cinnamoyl-3-Hydroxycyclohex-2-en-1-one Derivatives as Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors

Cinnamic acid, isolated from cinnamon bark, is a natural product with excellent bioactivity, and it effectively binds with cyclohexanedione to form novel 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors. According to the active sub-structure combinat

PHARMACEUTICALLY ACTIVE BENZOXAZOLE, BENZTHIAZOLE AND BENZIMIDAZOLE ACID DERIVATIVES

Compounds of formula (I): wherein R1, R2 and R3 are independently, hydrogen, halogen, CF3, OR6, NR7R8, NR8COR10, NR8SO2R10 or C1-6 alkyl optionally substituted by hydroxy, C1-6 alkoxy or NR7R8; R4 is NR8CONR8R9, NR8COR9, NR8SO2R9, or W-CONR8R9, where W is a bond, C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene; and R5 is Formula (A) methods for their synthesis, pharmaceutical compositions comprising them and their use in medicine, in particular for the treatment of cancer.